| Click here to view the January Issue |
![]() |
| Click here to view The 2009 Pharma Choice Awards |
![]() |
| Anna Stashower President/Publisher Welcome to PM360 |
|
COMMON SENSE By Bud Bilanich |
![]() |
| Lessons from the Healthcare Reform Debate |
IOM Comparative Effectiveness Research: Implications for Pharma Brand Teams
The Institute of Medicine (IOM) recently released its recommendation on the topics to study for comparative effectiveness. Many feared that this work would result in restrictions on the use of many prescription drugs and pressures for reduced prices.
To help pharmaceutical marketers to understand the potential impact of comparative effectiveness research (CER) on their business, Medical Marketing Economics has undertaken an in-depth analysis of the IOM report and is pleased to say that except for a few cases, prescription drugs in general are much more likely to benefit from these studies than to be harmed. Nine specific categories of drugs were listed to be evaluated for effectiveness among the 100 research initiatives outlined, and their priorities for evaluation are displayed in the graphic presented here.
The Customer Experience Maturity Monitor
Published by SAS, Peppers & Rogers and Jubelirer Research
In our hyper-networked marketplace, there are more customer channels and touch points to manage and keep in sync than ever before, creating new challenges in managing the customer experience. With the advances in technology and wider spread use of customer analytics, exactly how far have businesses come in harnessing the information to provide customers with an “exceptional” experience across channels? This paper, based on research with senior execs from Fortune 500 companies, uncovers what is working, what is broken and what priorities need to be established in order to build more profitable and mutually-valuable experiences with customers.
This paper will provide insight to:
Competing on Customer Intelligence
Published by SAS
This white paper is a practical guide for senior marketers and decision makers across the enterprise. It provides straightforward advice on how to build a more durable and profitable customer base by:
A Revolution in Physician Targeting: In-source analytics-driven intelligence to go beyond decile-based targeting
Published by SAS
Knowing that a physician has been a high prescriber in the past is no longer enough information to set you apart from the competition. Using advanced analytics in-house can help you predict outcomes of promotions and lead to more focused marketing – without having to rely on outside consultants. The paper includes case studies of several companies, including one that boosted earnings by $27 million over four months and another that saw a 19 percent gain in prescribing.
E-Marketing Activities
By Tom St. Peter
Results from 98 marketing professionals regarding current e-marketing activities. Find out what activities are being deployed and how effective the have been.
DOCTORS DEMAND MORE VALUE FROM SALES REPRESENTATIVES
New Survey from Sermo & Publicis Selling Solutions Group
Download results of the new survey—What Physicians Want!—conducted by Sermo and Publicis Selling Solutions Group. For other article downloads from Publicis Selling Solutions, please visit www.pSellingSolutions.com/resources
Journal Readership: Has Physician Behavior Changed?
By Tom St. Peter
Asheville, NC, May 2007. DoctorDirectory.com, a marketing services company, recently conducted a survey regarding journal readership among a multi-specialty sample of physicians. Results were obtained from nearly 2000 (N=1992) physicians that included cardiologists, gastroenterologists, neurologists, and oncologists. The nature of the study was to determine how many journals physicians read, the amount time spent reading, and what journals hold the highest interest for them.
SELLING DEVICES AND DIAGNOSTICS: The world is changing
By Medical Device & Diagnostics Executive
Few would disagree that the global healthcare environment is in the midst of some of the most radical change it has seen in recent times. Like all aspects of healthcare, the medical device industry is facing an ever dynamic landscape in which to do business. To meet the challenge, the industry too must adapt and change.